DELCATH SYSTEMS (NASDAQ:DCTH)
4.89
+0.48 (10.88%)
| DELCATH SYSTEMS (NASDAQ:DCTH) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $4.41 | 52 Week High | $6.35 | ||
| Open | $4.40 | 52 Week Low | $0.86 | ||
| Day High | $5.18 | P/E | N/A | ||
| Day Low | $4.37 | EPS | $-0.74 | ||
| Volume | 1,417,306 | ||||
| More DCTH Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| MVL | 2 | ANGO | 2 |
| AIG | 2 | AUTH | 2 |
| BHI | 2 | SVA | 2 |
| BJS | 2 | TSEM | 2 |
| CMM | 2 | DIS | 2 |
| KFN | 2 | HPGP | 1 |
Entities who have mentioned DCTH
- Canaccord Adams | View Related Stories »
- Cowen & Co | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Banc of America | View Related Stories »
- Barron's | View Related Stories »
- Raymond James | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Lazard | View Related Stories »
- JPMorgan | View Related Stories »
- Merrill Lynch | View Related Stories »
- American Technology Research | View Related Stories »
- Barclays | View Related Stories »
- Dividend | View Related Stories »
- Standard & Poor's | View Related Stories »
- Piper Jaffray | View Related Stories »
View All ReportsStreetInsider.com Reports on DCTH
- Delcath Systems (DCTH) Prices 8.5M Share Offering at $3.60/Share
- Delcath Systems (DCTH) Announces 8.5M Common Stock Offering
- Delcath Systems (DCTH) Announces Phase III Melanoma Study Fully Enrolled
- Delcath Systems (DCTH) Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
- Delcath Systems (DCHT) Names McDonald CFO
View All Press ReleasesCompany Press Releases on DCTH
- Delcath Systems Reports Substantial Progress
- Delcath Systems Announces Completion of Public Offering
- Delcath Systems to Present at Lazard Capital Markets 6th Annual Healthcare Conference
- Delcath Systems, Inc. Prices $30.6 Million Stock Offering
- Delcath Systems, Inc. Announces Public Offering of Common Stock
StreetInsider Reports on DCTH by Category
View All BlogsBlogs on DCTH
- BioMed News Bytes: AstraZeneca, Delcath, Unilife
- BioMed News: Antigenics, Shire, King Pharma, Delcath Systems
- Delcath jumps 18% as its chemotherapy agent gets orphan drug status
- Closing Update for Monday, August 31: Trimming August Gains
- Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
View All FilingsSEC Filings on DCTH
- Form 4 DELCATH SYSTEMS INC For: Nov 18 Filed by: STOLL ROGER G PHD
- Form 4 DELCATH SYSTEMS INC For: Nov 18 Filed by: Philips Laura A
- Form 4 DELCATH SYSTEMS INC For: Nov 18 Filed by: HOBBS EAMONN P
- Form 8-K DELCATH SYSTEMS INC For: Nov 12
- Form 10-Q DELCATH SYSTEMS INC For: Oct 21
Comments on DCTH
No comments are currently available.
